Drug intelligence / Profile preview

lycium chinense extract

Development stage
Unknown
Lead developer
Biomix
Administration
Oral, Topical
01

Overview

Lycium chinense extract is a botanical extract derived from the fruit of the Chinese wolfberry or goji berry, a plant in the Solanaceae family traditionally used in Chinese medicine. The extract is rich in bioactive compounds, including lycium polysaccharides, flavonoids, amino acids, and lignans such as lyciumlignan D and lyciumphenyl propanoid A. Clinical research, including studies by BIOMIX Company, has demonstrated its potential to enhance attention and cognitive function in healthy individuals. Preclinical evidence also suggests that the extract may ameliorate post-menopausal obesity and metabolic dysfunction by modulating the expression of Peroxisome proliferator-activated receptor gamma (PPAR-gamma), Glucose transporter type 4 (GLUT4), and Estrogen receptors (ER-alpha and ER-beta). Beyond its use as a functional food and medicinal herb for diabetes and inflammation, it is utilized as a cosmetic ingredient for its antioxidant and skin-soothing properties.

Other names
Lycium chinense Miller extractChinese wolfberry extractGoji berry extractLycium chinense fruit extract
02

Targets

ESR1 (ERα)ESR2 (ERβ)SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on lycium chinense extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lycium chinense extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call